{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:15:09Z","timestamp":1782782109422,"version":"3.54.5"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R15 AI138002"],"award-info":[{"award-number":["R15 AI138002"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI050243"],"award-info":[{"award-number":["R01 AI050243"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI129326"],"award-info":[{"award-number":["U19 AI129326"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["D43 TW001505"],"award-info":[{"award-number":["D43 TW001505"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>G6PD enzyme deficiency is a common enzymatic X-linked disorder. Deficiency of the G6PD enzyme can cause free radical-mediated oxidative damage to red blood cells, leading to premature haemolysis. Treatment of <jats:italic>Plasmodium vivax<\/jats:italic> malaria with primaquine poses a potential risk of mild to severe acute haemolytic anaemia in G6PD deficient people. In this study, the prevalence and distribution of G6PD mutations were investigated across broad areas of Ethiopia, and tested the association between G6PD genotype and phenotype with the goal to provide additional information relevant to the use of primaquine in malaria treatment.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study examined G6PD mutations in exons 3\u201311 for 344 febrile patient samples collected from seven sites across Ethiopia. In addition, the G6PD enzyme level of 400 febrile patient samples from Southwestern Ethiopia was determined by the CareStart\u2122 biosensor. The association between G6PD phenotype and genotype was examined by Fisher exact test on a subset of 184 samples.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Mutations were observed at three positions of the G6PD gene. The most common G6PD mutation across all sites was A376G, which was detected in 21 of 344 (6.1%) febrile patients. Thirteen of them were homozygous and eight were heterozygous for this mutation. The G267+119C\/T mutation was found in 4 (1.2%) individuals in South Ethiopia, but absent in other sites. The G1116A mutation was also found in 4 (1.2%) individuals from East and South Ethiopia. For the 400 samples in the south, 17 (4.25%) were shown to be G6PD-deficient. G6PD enzyme level was not significantly different by age or gender. Among a subset of 202 febrile patients who were diagnosed with malaria, 11 (5.45%) were G6PD-deficient. These 11 infected samples were diagnosed with <jats:italic>Plasmodium vivax<\/jats:italic> by microscopy. Parasitaemia was not significantly different between the G6PD-deficient and G6PD-normal infections.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of G6PD deficiency is modest among febrile patients in Ethiopia. G6PD deficiency testing is thus recommended before administrating primaquine for radical cure of <jats:italic>P. vivax<\/jats:italic> infected patients. The present study did not indicate a significant association between G6PD gene mutations and enzyme levels.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-019-2981-x","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:02:54Z","timestamp":1570449774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-4709","authenticated-orcid":false,"given":"Eugenia","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daibin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beka","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareen","family":"Pestana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Koepfli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delenasaw","family":"Yewhalaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"2981_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42:267\u201378.","journal-title":"Blood Cells Mol Dis"},{"key":"2981_CR2","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1061573","volume":"293","author":"SA Tishkoff","year":"2001","unstructured":"Tishkoff SA, Varkonyi R, Cahinhinan N, Abbes S, Argyropoulos G, Destro-Bisol G, et al. Haplotype diversity and linkage disequilibrium at human G6PD: recent origin of alleles that confer malarial resistance. Science. 2001;293:455\u201362.","journal-title":"Science"},{"key":"2981_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/hdy.2011.90","volume":"108","author":"L Luzzatto","year":"2012","unstructured":"Luzzatto L. G6PD deficiency and malaria selection. Heredity (Edinb). 2012;108:456.","journal-title":"Heredity (Edinb)."},{"key":"2981_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.4269\/ajtmh.13-0622","volume":"90","author":"G Sirugo","year":"2014","unstructured":"Sirugo G, Predazzi IM, Bartlett J, Tacconelli A, Walther M, Williams SM. G6PD A- deficiency and severe malaria in The Gambia: heterozygote advantage and possible homozygote disadvantage. Am J Trop Med Hyg. 2014;90:856\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2981_CR5","doi-asserted-by":"publisher","first-page":"e1004960","DOI":"10.1371\/journal.pgen.1004960","volume":"11","author":"A Manjurano","year":"2015","unstructured":"Manjurano A, Sepulveda N, Nadjm B, Mtove G, Wangai H, Maxwell C, et al. African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet. 2015;11:e1004960.","journal-title":"PLoS Genet"},{"key":"2981_CR6","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.","journal-title":"PLoS Med."},{"key":"2981_CR7","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"2981_CR8","doi-asserted-by":"publisher","first-page":"e0006230","DOI":"10.1371\/journal.pntd.0006230","volume":"12","author":"J Recht","year":"2018","unstructured":"Recht J, Ashley EA, White NJ. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: divergent policies and practices in malaria endemic countries. PLoS Negl Trop Dis. 2018;12:e0006230.","journal-title":"PLoS Negl Trop Dis."},{"key":"2981_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<174::AID-AJH18>3.0.CO;2-I","volume":"51","author":"DH Lee","year":"1996","unstructured":"Lee DH, Warkentin TE, Neame PB, Ali MA. Acute hemolytic anemia precipitated by myocardial infarction and pericardial tamponade in G6PD deficiency. Am J Hematol. 1996;51:174\u20135.","journal-title":"Am J Hematol"},{"key":"2981_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bcmd.2004.03.004","volume":"33","author":"A Drousiotou","year":"2004","unstructured":"Drousiotou A, Touma EH, Andreou N, Loiselet J, Angastiniotis M, Verrelli BC, et al. Molecular characterization of G6PD deficiency in Cyprus. Blood Cells Mol Dis. 2004;33:25\u201330.","journal-title":"Blood Cells Mol Dis"},{"key":"2981_CR11","unstructured":"WHO. Testing for G6PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria. Geneva: World Health Organization; 2016. \n                    https:\/\/www.who.int\/malaria\/publications\/atoz\/g6pd-testing-pq-radical-cure-vivax\/en\/\n                    \n                  ."},{"key":"2981_CR12","unstructured":"WHO. Updated WHO Policy Recommendation (October 2012): Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria. Geneva: World Health Organization; 2012. \n                    https:\/\/www.who.int\/malaria\/publications\/atoz\/who_pq_policy_recommendation\/en\/\n                    \n                  ."},{"key":"2981_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/1475-2875-12-391","volume":"12","author":"GJ Domingo","year":"2013","unstructured":"Domingo GJ, Satyagraha AW, Anvikar A, Baird K, Bancone G, Bansil P, et al. G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J. 2013;12:391.","journal-title":"Malar J."},{"key":"2981_CR14","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1475-2875-10-351","volume":"10","author":"D Fernando","year":"2011","unstructured":"Fernando D, Rodrigo C, Rajapakse S. Primaquine in vivax malaria: an update and review on management issues. Malar J. 2011;10:351.","journal-title":"Malar J."},{"key":"2981_CR15","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","volume":"120","author":"A Pamba","year":"2012","unstructured":"Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono A, et al. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase\u2013deficient children receiving dapsone. Blood. 2012;120:4123\u201333.","journal-title":"Blood"},{"key":"2981_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","volume":"21","author":"PJ Mason","year":"2007","unstructured":"Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007;21:267\u201383.","journal-title":"Blood Rev"},{"key":"2981_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64\u201374.","journal-title":"Lancet"},{"key":"2981_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/1475-2875-12-289","volume":"12","author":"D Nantakomol","year":"2013","unstructured":"Nantakomol D, Paul R, Palasuwan A, Day NP, White NJ, Imwong M. Evaluation of the phenotypic test and genetic analysis in the detection of the glucose-6-phosphate dehydrogenase deficiency. Malar J. 2013;12:289.","journal-title":"Malar J."},{"key":"2981_CR19","unstructured":"WHO. Control and elimination of Plasmodium vivax malaria\u2014a technical brief. Geneva: World Health Organization; 2015. \n                    https:\/\/www.who.int\/malaria\/publications\/atoz\/9789241509244\/en\/\n                    \n                  ."},{"key":"2981_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"DR Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2006;75:402\u201315.","journal-title":"Am J Trop Med Hyg"},{"key":"2981_CR21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12936-015-0938-2","volume":"14","author":"L Gonzalez-Ceron","year":"2015","unstructured":"Gonzalez-Ceron L, Rodriguez MH, Sandoval MA, Santillan F, Galindo-Virgen S, Betanzos AF, et al. Effectiveness of combined chloroquine and primaquine treatment in 14\u00a0days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico. Malar J. 2015;14:426.","journal-title":"Malar J."},{"key":"2981_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4269\/ajtmh.13-0053","volume":"91","author":"S Durand","year":"2014","unstructured":"Durand S, Cabezas C, Lescano AG, Galvez M, Gutierrez S, Arrospide N, et al. Efficacy of three different regimens of primaquine for the prevention of relapses of Plasmodium vivax malaria in the Amazon Basin of Peru. Am J Trop Med Hyg. 2014;91:18\u201326.","journal-title":"Am J Trop Med Hyg"},{"key":"2981_CR23","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/j.1460-2075.1986.tb04436.x","volume":"5","author":"G Martini","year":"1986","unstructured":"Martini G, Toniolo D, Vulliamy T, Luzzatto L, Dono R, Viglietto G, et al. Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J. 1986;5:1849\u201355.","journal-title":"EMBO J"},{"key":"2981_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10930-013-9518-x","volume":"32","author":"S Gomez-Manzo","year":"2013","unstructured":"Gomez-Manzo S, Terron-Hernandez J, de la Mora I, Garcia-Torres I, Lopez-Velazquez G, Reyes-Vivas H, et al. Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield. Protein J. 2013;32:585\u201392.","journal-title":"Protein J."},{"key":"2981_CR25","doi-asserted-by":"publisher","first-page":"37284","DOI":"10.1038\/srep37284","volume":"6","author":"CG Doss","year":"2016","unstructured":"Doss CG, Alasmar DR, Bux DI, Sneha P, Bakhsh FD, Al-Azwani I, et al. Genetic epidemiology of glucose-6-phosphate dehydrogenase deficiency in the Arab World. Sci Rep. 2016;6:37284.","journal-title":"Sci Rep."},{"key":"2981_CR26","doi-asserted-by":"publisher","first-page":"e0166977","DOI":"10.1371\/journal.pone.0166977","volume":"11","author":"SK Sarker","year":"2016","unstructured":"Sarker SK, Islam MT, Eckhoff G, Hossain MA, Qadri SK, Muraduzzaman AK, et al. Molecular analysis of glucose-6-phosphate dehydrogenase gene mutations in Bangladeshi Individuals. PLoS One. 2016;11:e0166977.","journal-title":"PLoS One"},{"key":"2981_CR27","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","volume":"84","author":"E Beutler","year":"1994","unstructured":"Beutler E. G6PD deficiency. Blood. 1994;84:3613\u201336.","journal-title":"Blood"},{"key":"2981_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-015-0596-4","volume":"14","author":"E Lo","year":"2015","unstructured":"Lo E, Yewhalaw D, Zhong D, Zemene E, Degefa T, Tushune K, et al. Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia. Malar J. 2015;14:84.","journal-title":"Malar J."},{"key":"2981_CR29","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/1475-2875-13-438","volume":"13","author":"A Tsegaye","year":"2014","unstructured":"Tsegaye A, Golassa L, Mamo H, Erko B. Glucose-6-phosphate dehydrogenase deficiency among malaria suspects attending Gambella hospital, southwest Ethiopia. Malar J. 2014;13:438.","journal-title":"Malar J."},{"key":"2981_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4269\/ajtmh.17-0557","volume":"98","author":"TE Carter","year":"2018","unstructured":"Carter TE, Mekonnen SK, Lopez K, Bonnell V, Damodaran L, Aseffa A, et al. Glucose-6-phosphate dehydrogenase deficiency genetic variants in malaria patients in Southwestern Ethiopia. Am J Trop Med Hyg. 2018;98:83\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"2981_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4269\/ajtmh.2005.72.249","volume":"72","author":"S Bereczky","year":"2005","unstructured":"Bereczky S, Martensson A, Gil JP, Farnert A. Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. Am J Trop Med Hyg. 2005;72:249\u201351.","journal-title":"Am J Trop Med Hyg"},{"key":"2981_CR32","unstructured":"WHO. In vitro diagnostics medical devices to identify Glucose-6-phosphate dehydrogenase (\u200eG6PD)\u200e activity.\u00a0Geneva: World Health Organization; 2016. \n                    https:\/\/apps.who.int\/iris\/handle\/10665\/252628\n                    \n                  . Accessed 25 Apr 2019."},{"key":"2981_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12936-019-2652-y","volume":"18","author":"G Bancone","year":"2019","unstructured":"Bancone G, Menard D, Khim N, Kim S, Canier L, et al. Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion. Malar J. 2019;18:20.","journal-title":"Malar J."},{"key":"2981_CR34","doi-asserted-by":"publisher","first-page":"e0169930","DOI":"10.1371\/journal.pone.0169930","volume":"12","author":"B Ley","year":"2017","unstructured":"Ley B, Alam MS, O\u2019Donnell JJ, Hossain MS, Kibria MG, Jahan N, et al. A comparison of three quantitative methods to estimate G6PD activity in the Chittagong Hill Tracts, Bangladesh. PLoS One. 2017;12:e0169930.","journal-title":"PLoS One."},{"key":"2981_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12936-018-2437-8","volume":"17","author":"G Shitaye","year":"2018","unstructured":"Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, et al. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches. Malar J. 2018;17:281.","journal-title":"Malar J."},{"key":"2981_CR36","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12936-016-1440-1","volume":"15","author":"LE Amoah","year":"2016","unstructured":"Amoah LE, Opong A, Ayanful-Torgby R, Abankwa J, Acquah FK. Prevalence of G6PD deficiency and Plasmodium falciparum parasites in asymptomatic school children living in southern Ghana. Malar J. 2016;15:388.","journal-title":"Malar J."},{"key":"2981_CR37","doi-asserted-by":"publisher","first-page":"45963","DOI":"10.1038\/srep45963","volume":"7","author":"EC Mbanefo","year":"2017","unstructured":"Mbanefo EC, Ahmed AM, Titouna A, Elmaraezy A, Trang NT, Phuoc Long N, et al. Association of glucose-6-phosphate dehydrogenase deficiency and malaria: a systematic review and meta-analysis. Sci Rep. 2017;7:45963.","journal-title":"Sci Rep."},{"key":"2981_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s10038-005-0276-2","volume":"50","author":"C Louicharoen","year":"2005","unstructured":"Louicharoen C, Nuchprayoon I. G6PD Viangchan (871G\u2009>\u2009A) is the most common G6PD-deficient variant in the Cambodian population. J Hum Genet. 2005;50:448\u201352.","journal-title":"J Hum Genet"},{"key":"2981_CR39","doi-asserted-by":"publisher","first-page":"e11553","DOI":"10.1097\/MD.0000000000011553","volume":"97","author":"Y Chen","year":"2018","unstructured":"Chen Y, Xiu W, Dong Y, Wang J, Zhao H, Su Y, et al. Mutation of glucose-6-phosphate dehydrogenase deficiency in Chinese Han children in eastern Fujian. Medicine (Baltimore). 2018;97:e11553.","journal-title":"Medicine (Baltimore)."},{"key":"2981_CR40","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12936-018-2538-4","volume":"17","author":"A Assefa","year":"2018","unstructured":"Assefa A, Ali A, Deressa W, Tsegaye W, Abebe G, Sime H, et al. Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. Malar J. 2018;17:388.","journal-title":"Malar J."},{"key":"2981_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4269\/ajtmh.14-0100","volume":"91","author":"ME von Fricken","year":"2014","unstructured":"von Fricken ME, Weppelmann TA, Eaton WT, Masse R, Rochars MV, Okech BA. Performance of the CareStart\u2122 glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg. 2014;91:77\u201380.","journal-title":"Am J Trop Med Hyg."},{"key":"2981_CR42","doi-asserted-by":"publisher","first-page":"e0125796","DOI":"10.1371\/journal.pone.0125796","volume":"10","author":"D Adu-Gyasi","year":"2015","unstructured":"Adu-Gyasi D, Asante KP, Newton S, Dosoo D, Amoako S, Adjei G, et al. Evaluation of the diagnostic accuracy of CareStart\u2122 G6PD deficiency Rapid Diagnostic Test (RDT) in a malaria endemic area in Ghana, Africa. PLoS One. 2015;10:e0125796.","journal-title":"PLoS One."},{"key":"2981_CR43","doi-asserted-by":"publisher","first-page":"e28357","DOI":"10.1371\/journal.pone.0028357","volume":"6","author":"S Kim","year":"2011","unstructured":"Kim S, Nguon C, Guillard B, Duong S, Chy S, Sum S, et al. Performance of the CareStart\u2122 G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening. PLoS One. 2011;6:e28357.","journal-title":"PLoS One"},{"key":"2981_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1590\/0037-8682-0003-2017","volume":"50","author":"WM Monteiro","year":"2017","unstructured":"Monteiro WM, Brito MAM, Lacerda MVG. Accuracy of CareStart\u2122 G6PD rapid diagnostic test: variation in results from different commercial versions. Rev Soc Bras Med Trop. 2017;50:282\u20133.","journal-title":"Rev Soc Bras Med Trop"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-019-2981-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-019-2981-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T23:09:39Z","timestamp":1601939379000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-019-2981-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2981"],"URL":"https:\/\/doi.org\/10.1186\/s12936-019-2981-x","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by the Institutional Scientific and Ethical Review Boards of Institute of Health, Jimma University, Ethiopia and University of California, Irvine, USA. Written informed consent\/assent was obtained from all consenting heads of households, parents\/guardians, and each individual who was willing to participate in the study. All experimental procedures were performed following the IRB approved protocol.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"340"}}